Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice
Conditions
- Osteoporosis, Postmenopausal
Interventions
Sponsor
Amgen
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]